Clinical Trial Update: The Conversion Therapy of Chemotherapy Plus Camrelizumab in Metastatic Gastric Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating chemotherapy plus camrelizumab as conversion therapy in metastatic gastric cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Stomach Neoplasms

Drugs mentioned

• Camrelizumab (camrelizumab)
• Chemotherapy (chemotherapy)

Snippet

Sponsor: Quan Wang | Conditions: Stomach Neoplasms | Phase 2 | Status: COMPLETED